A Phase III Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Active Ankylosing Spondylitis

NCT06378697 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
510
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Akeso